dpp-4 inhibitors and glp-1 agonists DPP4 Inhibitor Mechanism of Action – My Endo Consult Clinical Use of DPP-4 Inhibitors

Modeling energy intake and body weight effects of a long-acting amylin analogue

Cox DJ, Kovatchev BP, Gonder-Frederick LA, Summers KH, McCall A, Grimm KJ, et al

While nausea is common and expected, it does not necessarily indicate the medication is working better

Dulaglutide prevented the death of cardiomyocytes in rodent HF models by maintaining cardiac function and reducing oxidative stress markers by 3040% [30]

Parkinson Disease Parkinson disease is a neurodegenerative disorder that predominantly affects the dopamine-producing neurons in the substantia nigra and causes tremors, muscle rigidity, and other movement-related symptoms that become progressively more debilitating with time